Lowes Companies Inc
—- Market cap
- —
- Debt
- —
- Cash
- −$982.00M
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: LOW stock price vs CVS: inconclusive — current versus $812.36 implied using P/E multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at CVS's multiple
Implied fair value · at LOW's multiple
Needs LOW P/E.
Snapshot Sep 10, 2026, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
17 period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 65% equity / 35% debt · EV / Revenue 0.44x · EV proxy / EBITDA proxy 19.21x
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
LOWES COMPANIES INC · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
CVS HEALTH CORPORATION · implied price per share
Bear
$54.13
Base
$73.03
Bull
$98.52
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
HOME DEPOT, INC.
LOW vs HD
SHERWIN WILLIAMS CO
LOW vs SHW
WILLIAMS SONOMA INC
LOW vs WSM
Tractor Supply Company
LOW vs TSCO
Walgreens Boots Alliance, Inc.
LOW vs WBA
UNITEDHEALTH GROUP INC
LOW vs UNH
Walmart Inc.
LOW vs WMT
Cigna Group
LOW vs CI
HUMANA INC
LOW vs HUM
Elevance Health, Inc.
LOW vs ELV
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe LOW will sustain its superior margins and lower leverage while the P/E-based implied price is overstated by the model inputs, then hold or selectively add on pullbacks because the business quality is clearly better than CVS but the stock is already close to the top of its historical valuation band.
On a P/E basis, LOW trades at 17.2x versus CVS at 79.6x, yet the valuation output implies a $942.88 price for LOW and 363.3% upside, which looks inconsistent with the rest of the dataset. LOW also sits near the upper end of its historical band at $203.51 versus $183.16-$223.86, suggesting limited immediate re-rating room.
Supporting Metrics